Patient-reported outcome results from the open-label phase III AURELIA trial evaluating bevacizumab-containing therapy for platinum-resistant ovarian cancer. (Q36925044)
Jump to navigation
Jump to search
scientific article published on 31 March 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Patient-reported outcome results from the open-label phase III AURELIA trial evaluating bevacizumab-containing therapy for platinum-resistant ovarian cancer. |
scientific article published on 31 March 2014 |
Statements
Patient-reported outcome results from the open-label phase III AURELIA trial evaluating bevacizumab-containing therapy for platinum-resistant ovarian cancer (English)
Felix Hilpert
Mansoor Raza Mirza
Martin R Stockler
Michael Friedlander
Madeleine T King
Lari Wenzel
Nikolaus de Gregorio
José Angel Arranz
Roberto Sorio
Ulrich Freudensprung
Vesna Sneller
Gill Hales
Eric Pujade-Lauraine
1 reference
1 reference